We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

173 hedge funds and large institutions have $315M invested in Rocket Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

98% more call options, than puts

Call options by funds: $2.87M | Put options by funds: $1.45M

35% more capital invested

Capital invested by funds: $233M → $315M (+$81.8M)

0.53% more ownership

Funds ownership: 88.98% → 89.52% (+0.53%)

2% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 62

12% less funds holding

Funds holding: 196 → 173 (-23)

44% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 50

Holders
173
Holders Change
-23
Holders Change %
-11.73%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
61
Reduced
62
Closed
50
Calls
$2.87M
Puts
$1.45M
Net Calls
+$1.42M
Net Calls Change
+$925K

Top Buyers

1
MAM
Monaco Asset Management
Monaco
+$7.68M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.77M
3
Millennium Management
Millennium Management
New York
+$3.85M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.77M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.72M

Top Sellers

1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$2.69M
2
CSS
Cubist Systematic Strategies
Connecticut
-$1.76M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.68M
4
WP
Woodline Partners
California
-$1.6M
5
N
Nuveen
North Carolina
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
51
Amitell Capital
Singapore
$583K -$152K -48,231 -21%
N
52
Nuveen
North Carolina
$515K -$1.51M -480,503 -75%
AllianceBernstein
53
AllianceBernstein
Tennessee
$513K -$72K -22,850 -13%
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$511K -$60K -19,065 -11%
Creative Planning
55
Creative Planning
Kansas
$505K +$351K +111,514 +257%
Barclays
56
Barclays
United Kingdom
$487K -$78.9K -25,045 -14%
XT
57
XTX Topco
Cayman Islands
$481K +$41.1K +13,056 +10%
Renaissance Technologies
58
Renaissance Technologies
New York
$447K -$1.02M -324,197 -70%
GCM
59
Graham Capital Management
Connecticut
$435K -$330K -104,738 -44%
Raymond James Financial
60
Raymond James Financial
Florida
$423K +$22.6K +7,188 +6%
EC
61
EntryPoint Capital
New York
$409K -$553K -175,463 -58%
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$394K +$1.54K +489 +0.4%
SFI
63
Susquehanna Fundamental Investments
Pennsylvania
$390K -$270K -85,765 -42%
Rockefeller Capital Management
64
Rockefeller Capital Management
New York
$349K +$31.5K +10,000 +10%
Mirae Asset Global ETFs Holdings
65
Mirae Asset Global ETFs Holdings
Hong Kong
$342K -$23.5K -7,463 -7%
TD Asset Management
66
TD Asset Management
Ontario, Canada
$334K -$228K -72,372 -41%
MA
67
MYDA Advisors
New York
$326K – – –
BFM
68
Boothbay Fund Management
New York
$322K +$311K +98,741 New
BP
69
Ballentine Partners
Massachusetts
$289K +$279K +88,570 New
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
$285K -$204K -64,900 -43%
LPC
71
Lion Point Capital
New York
$280K +$271K +86,000 New
QC
72
Quadrature Capital
United Kingdom
$279K -$22.3K -7,079 -8%
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$273K – – –
RHJA
74
Rice Hall James & Associates
California
$271K -$29.6K -9,391 -10%
IC
75
IEQ Capital
California
$265K +$133K +42,125 +108%
1 2
3
4 5

RCKT Hedge Fund Activity: Q3 2025 in Review

173 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2025, worth a combined $315M — up 35% from $233M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of RCKT and 28 opened new positions — a net loss of 22 holders — while 62 trimmed existing stakes and 61 added.

The largest buyer was Monaco Asset Management, adding an estimated $7.68M. The largest seller was Toronto Dominion Bank, exiting entirely with an estimated $2.69M sold.

  • 173 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2025, down from 196 in Q2 2025.
  • Funds reported $315M of Rocket Pharmaceuticals stock for Q3 2025, up 35% quarter-over-quarter.
  • 28 funds opened new Rocket Pharmaceuticals positions in Q3 2025 and 50 closed out, a net change of -22 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2025 was Monaco Asset Management, an estimated $7.68M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2025 was Toronto Dominion Bank, an estimated $2.69M sold.

Based on aggregated 13F filings for Q3 2025.